Ken Watanabe

Scopus Author ID Researcher Name Resolver ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2020
Publications (10 Years): 3

Top Topics

High Throughput

Coronavirus Disease

Electronic Health Record

Top Venues

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Juliann Nzembi Makau, Ken Watanabe, Hiroki Otaki, Satoshi Mizuta, Takeshi Ishikawa, Yuji O Kamatari, Noriyuki Nishida
A Quinolinone Compound Inhibiting the Oligomerization of Nucleoprotein of Influenza A Virus Prevents the Selection of Escape Mutants. Viruses 12 (3) (2020)
Ken Watanabe
Drug-Repositioning Approach for the Discovery of Anti-Influenza Virus Activity of Japanese Herbal (Kampo) Medicines In Vitro: Potent High Activity of Daio-Kanzo-To. Evidence-based complementary and alternative medicine : eCAM 2018 (2018)
Satoshi Mizuta, Juliann Nzembi Makau, Ayako Kitagawa, Kanami Kitamura, Hiroki Otaki, Kodai Nishi, Ken Watanabe
Synthesis of Trifluoromethyl-α,β-unsaturated Lactones and Pyrazolinones and Discovery of Influenza Virus Polymerase Inhibitors. ChemMedChem 13 (22) (2018)